Skip to main content

Opinion: Boycotting Elsevier Is Not Enough

The publishing giant will likely survive the latest boycott by scientists. An overhaul is needed to make science publishing fair and open.

Written byShaun Khoo
| 4 min read
boycott petition elsevier academic scholarly publishing open access

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, LEREMY

All of this has happened before. A group of scientists, upset with the extraordinarily profitable Elsevier, have announced its intention to boycott the publisher. In 2012, mathematicians led the Cost of Knowledge boycott. This time, it’s University of California (UC) scientists upset about the breakdown of negotiations that sought to combine journal subscriptions with open-access publishing. Unfortunately, on its own, this boycott will do little to change science publishing.

Many scientists struggle to see the value Elsevier provides. Elsevier usually demands a high price to publish a paper—on the order of $4,000–$5,000—and has also shown a willingness to play hardball in negotiations with whole countries. Importantly, Elsevier’s authors, reviewers, and most editors never receive any of this money.

Boycotting Elsevier is therefore a reasonable response from dissatisfied stakeholders. In theory, if boycotters provide their authoring, reviewing, and editing expertise for publishers with better copyright and access ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Share
Related articles background image
July digest cover
July 2026

Polyacrylamide Gels Turn into Mini Sculptures

Instead of discarding used polyacrylamide gels, biochemist Palina Kot reshapes them into artworks that reflect the realities of scientific research.

View this Issue
Understanding How the Tumor Microenvironment Reshapes Anti-Tumor Immunity

Understanding How the Tumor Microenvironment Reshapes Anti-Tumor Immunity

bioxcell
Accelerating AI-Guided Antibody Discovery in Under Five Weeks

Accelerating AI-Guided Antibody Discovery in Under Five Weeks

Twist Bio 
Standardizing Oncology NGS for Biomarker-Ready Translational Research

Standardizing Oncology NGS for Biomarker-Ready Translational Research

Danaher Logo
Repairing the Injured Nervous System With Stem Cells

Repairing the Injured Nervous System With Stem Cells

Biotium

Products

OrganaBio Logo

OrganaBio Expands Rapid PBMC Processing to San Diego at Excellos Labs

Bio-Rad Logo

Bio-Rad Launches Vericheck ddPCR Kits Compatible with QX700 Platform for Biopharma Quality Control and Cell and Gene Therapy Workflows

Eppendorf Logo

Eppendorf Focuses Outreach Programmes to Advance STEM Education in Europe

Lonza logo

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

Morty Proxy This is a proxified and sanitized view of the page, visit original site.